S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study
The study demonstrated the reasonable efficacy and promising safety of the S-1-Nimo-based CCRT in LA-ESCC patients with failure to neoadjuvant chemotherapy or chemoimmunotherapy.
Authors
- Zefen Xiao (ORCID: https://orcid.org/0000-0003-0503-6814)
- Xin Wang (ORCID: https://orcid.org/0000-0002-3149-108X)
- Xiankai Chen (ORCID: https://orcid.org/0000-0002-8580-7246)
- Wenyang Liu (ORCID: https://orcid.org/0000-0002-6978-7169)
- Lei Deng (ORCID: https://orcid.org/0000-0001-8867-6635)
- Zongmei Zhou (ORCID: https://orcid.org/0000-0002-8336-2319)
- Qinfu Feng
- Nan Bi
- Xiaozheng Kang (ORCID: https://orcid.org/0000-0003-0334-1487)
- Tao Zhang (ORCID: https://orcid.org/0000-0001-5907-5312)
- Yong Li (ORCID: https://orcid.org/0000-0003-1799-4841)
- Wenqing Wang (ORCID: https://orcid.org/0000-0002-6710-4045)
- Jiao Li (ORCID: https://orcid.org/0000-0002-1996-004X)
- Guojie Feng
- Jianyang Wang (ORCID: https://orcid.org/0000-0002-1430-4158)
- Nuo Yu (ORCID: https://orcid.org/0000-0001-8796-6112)
- Ziyu Zheng (ORCID: https://orcid.org/0000-0001-8221-3541)
- Xiongtao Yang (ORCID: https://orcid.org/0000-0002-6961-2799)
- Jianjun Qin (ORCID: https://orcid.org/0000-0002-2008-6193)
- Ruixiang Zhang (ORCID: https://orcid.org/0009-0009-3728-5170)
- Zhen Wang (ORCID: https://orcid.org/0009-0004-5437-1103)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Cancer Biology & Therapy
- Published
- 2024-10-27
- DOI
- https://doi.org/10.1080/15384047.2024.2417464
- Citations
- 2
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- Beijing Xisike Clinical Oncology Research Foundation